Literature DB >> 17659388

Leishmania major infection in a patient with visceral leishmaniasis: treatment with Amphotericin B.

Mehdi Karamian1, Mohammad Hossein Motazedian, Davood Mehrabani, Khodakaram Gholami.   

Abstract

We have reported an acute form of visceral leishmaniasis, which was caused by Leishmania major, in Southern Iran. The parasite was isolated from a 30-year-old man living in Bushehr Province, Southern Iran, and an endemic region of kala-azar in south of Iran. The patient had typical clinical signs of Mediterranean kala-azar, and besides parasitological, biochemical, and immunological findings confirming diagnosis of visceral leishmaniasis, the agent was identified as L. major using Nested polymerase chain reaction. The patient was treated successfully with Amphotericin B during a 1-month period.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17659388     DOI： 10.1007/s00436-007-0649-x

Source DB:  PubMed          Journal:  Parasitol Res        ISSN： 0932-0113            Impact factor:   2.289


  17 in total

Review 1.  [Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].

Authors:  A Magnan; P Jacquème; N Sudan; E Redding; A P Blanc; R Poirier
Journal:  Rev Pneumol Clin       Date:  1991

2.  Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate.

Authors:  F Garcia-Cordoba; F J Ortuño; M Segovia; G Gonzalez Diaz
Journal:  Ann Trop Med Parasitol       Date:  2005-03

3.  Indian kala-azar caused by Leishmania tropica.

Authors:  D L Sacks; R T Kenney; R D Kreutzer; C L Jaffe; A K Gupta; M C Sharma; S P Sinha; F A Neva; R Saran
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

4.  Visceral infection due to Leishmania tropica in a veteran of Operation Desert Storm who presented 2 years after leaving Saudi Arabia.

Authors:  A J Magill; M Grogl; S C Johnson; R A Gasser
Journal:  Clin Infect Dis       Date:  1994-10       Impact factor: 9.079

5.  DNA extraction and amplification of leishmania from archived, Giemsa-stained slides, for the diagnosis of cutaneous Leishmaniasis by PCR.

Authors:  H Motazedian; M Karamian; H A Noyes; S Ardehali
Journal:  Ann Trop Med Parasitol       Date:  2002-01

6.  A nested-PCR-based schizodeme method for identifying Leishmania kinetoplast minicircle classes directly from clinical samples and its application to the study of the epidemiology of Leishmania tropica in Pakistan.

Authors:  H A Noyes; H Reyburn; J W Bailey; D Smith
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

7.  Seroepidemiological study of visceral leishmaniasis among humans and animal reservoirs in Bushehr province, Islamic Republic of Iran.

Authors:  M Mohebali; Y Hamzavi; G H Edrissian; A Forouzani
Journal:  East Mediterr Health J       Date:  2001-11       Impact factor: 1.628

8.  Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts.

Authors:  J Kubar; P Marty; A Lelièvre; J F Quaranta; P Staccini; C Caroli-Bosc; Y Le Fichoux
Journal:  AIDS       Date:  1998-11-12       Impact factor: 4.177

9.  Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent.

Authors:  Mary Ann McDowell; Mary Marovich; Rosalia Lira; Michael Braun; David Sacks
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  Leishmania infantum leishmaniasis in corticosteroid--treated patients.

Authors:  Silvia Pittalis; Emanuele Nicastri; Francesco Spinazzola; Piero Ghirga; Michele De Marco; Maria Grazia Paglia; Pasquale Narciso
Journal:  BMC Infect Dis       Date:  2006-12-18       Impact factor: 3.090
View more
  15 in total

1.  Leishmania major protein disulfide isomerase as a drug target: enzymatic and functional characterization.

Authors:  Noureddine Ben Khalaf; Géraldine De Muylder; Hechmi Louzir; James McKerrow; Mehdi Chenik
Journal:  Parasitol Res       Date:  2011-12-09       Impact factor: 2.289

Review 2.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-11-17

3.  Effectiveness of Short-Course Meglumine Antimoniate (Glucantime®) for Treatment of Visceral Leishmaniasis: A 13-Year, Multistage, Non-Inferiority Study in Iran.

Authors:  Abdolvahab Alborzi; Gholamreza Pouladfar; Armin Attar; Fatemeh Falahi; Zahra Jafarpour; Abdollah Karimi; Mohammad Rahim Kadivar
Journal:  Am J Trop Med Hyg       Date:  2016-11-22       Impact factor: 2.345

4.  Comparative study of viscerotropic pathogenicity of Leishmania major amastigotes and promastigotes based on identification of mitochondrial and nucleus sequences.

Authors:  Adel Spotin; Parviz Parvizi
Journal:  Parasitol Res       Date:  2015-12-03       Impact factor: 2.289

Review 5.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-12-01

6.  Population structures of Leishmania infantum and Leishmania tropica the causative agents of kala-azar in Southwest Iran.

Authors:  Mohammad Amin Ghatee; Hossein Mirhendi; Mehdi Karamian; Walter R Taylor; Iraj Sharifi; Massood Hosseinzadeh; Zahra Kanannejad
Journal:  Parasitol Res       Date:  2018-08-13       Impact factor: 2.289

7.  Intestinal leishmaniasis in acquired immunodeficiency syndrome.

Authors:  M Molaei; M Minakari; Sh Pejhan; R Mashayekhi; A R Modaress Fatthi; M R Zali
Journal:  Iran Red Crescent Med J       Date:  2011-05-01       Impact factor: 0.611

8.  Epidemiological features of visceral leishmaniasis in fars province, southern iran.

Authors:  B Sarkari; G Hatam; Ma Ghatee
Journal:  Iran J Public Health       Date:  2012-04-30       Impact factor: 1.429

9.  Leishmania major infection in humanized mice induces systemic infection and provokes a nonprotective human immune response.

Authors:  Anja Kathrin Wege; Christian Florian; Wolfgang Ernst; Nicole Zimara; Ulrike Schleicher; Frank Hanses; Maximilian Schmid; Uwe Ritter
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24

10.  Hoarseness as the Presenting Symptom of Visceral Leishmaniasis with Muco-Cutaneous Lesions: A Case Report.

Authors:  Hossein Mortazavi; Mehdi Mohebali; Yasaman Taslimi; Pardis Sadeghipour; Mahsa Ansari; Kambiz Kamyab; Marjan Talebi; Ali Khamesipour
Journal:  Iran J Parasitol       Date:  2015 Apr-Jun       Impact factor: 1.012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.